Preintervention Wait Time and Survival in People With Rheumatic Heart Disease in Uganda

Written By RRCU Staff

Chang Yoon Doh, BS,1 Crystal An, BS,1 Andrew Y. Chang, MD, MS,2,3,4 Joselyn Rwebembera, MBChB, MMed,5 Tom P. Mwambu, MBChB, MMed,6,7 Andrea Z. Beaton, MD,8,9 Doreen Nakagaayi, MBChB, MMed,5,8 Pablo F. Ruda Vega, MD,10 Craig A. Sable, MD,11,12 Chris T. Longenecker, MD,13, and Peter Lwabi, MBChB, MMed5,7

Ann Thorac Surg 2024

Back to Publications
RRCU Staff
Previous

Integrating secondary prevention of rheumatic heart disease into the primary healthcare system in Northern Uganda
Next

Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial)